AMD Awareness Week 2015 takes place from 14 to 20 September
Events in the UK and worldwide planned to raise awareness of macular degeneration (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 15, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Ophthalmology amd AMD Alliance Latest News macular degeneration our eyes matter Source Type: news
Specialise in diabetes, urges national pharmacist leader
Advice from Philip Newland-Jones, the Royal Pharmaceutical Society's Leadership Award winner (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 15, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Diabetes Patient care Policy & practice Council of Healthcare Professionals diabetes uk Latest News royal pharmaceutical society leadership award RPS type 2 diabetes Source Type: news
Updated label for Daklinza for the treatment of chronic hepatitis C genotype 3 approved by the EC
Daklinza in combination with sofosbuvir is the first 12-week all-oral therapy for genotype 3 patients without cirrhosis in Europe (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 14, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Pharmacogenetics Legislation & regulation Hepatic disorders Patient care ALLY-3 cirrhosis combination daklinza genotype 3 chronic hepatitis C hcv Latest News ribaviri Source Type: news
International statements for hospital pharmacy revised
Global standards of practice used by hospital pharmacists around the world have been revised (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 10, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Guidelines Policy & practice basel statements fip FIP-World Health Organization Good Pharmacy Practice hospital pharmacy HPS Latest News standard of pracice Source Type: news
Janssen submits Marketing Authorisation Application for daratumumab
Daratumumab is for European patients with heavily pre-treated multiple myeloma (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 9, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics mAbs Haematology Oncology Research anti-CD38 monoclonal antibody daratumumab GEN501 immunomodulatory agents Latest News MMY2002 multiple myeloma Source Type: news
NICE says ‘yes’ to new option for rheumatoid arthritis
NICE recommends RoActemra® (tocilizumab) as monotherapy for treatment of severe rheumatoid arthritis (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 4, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Guidelines Legislation & regulation Rheumatology Patient care ADACTA anti-TNF monotherapy cDMARDs Latest News nice rheumatoid arthritis roactemra severe RA tocilizu Source Type: news
Sandoz launches Zarxio (TM) (filgrastim-sndz), the first biosimilar in the United States
Launch follows March 6, 2015 FDA approval. Sandoz One SourceTM offers patient support services (Source: Pharmacy Europe)
Source: Pharmacy Europe - September 3, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Biosimilars Clinical trials Practical therapeutics Oncology fda approval filgrastim-sndz Latest News zarxio Source Type: news
NICE publishes positive final guidance on Entyvio® (vedolizumab)
NICE recommends vedolizumab as an option for adults with moderately to severely active Crohn’s Disease (CD) who have either failed,* or were intolerant or contraindicated to, a tumour necrosis factor alpha inhibitor (anti-TNF) (1) (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 27, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Legislation & regulation Gastroenterology anti-TNF crohn's disease Latest News NICE guidance ulcerative colitis vedolizumab Source Type: news
Oxford starts on biggest ever genetic recruitment project
A project to unravel the genetic changes underlying rare disease and cancers of more than 1200 patients and their families who are looked after by Oxford University Hospitals NHS Trust (OUHT) has started (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 27, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Pharmacogenetics Research 000 Genomes Project 100 genome sequencing Latest News oxford university hospitals Source Type: news
Janssen submits European extension marketing authorisation application for paliperidone palmitate
First long-acting treatment to be administered four times a year for the treatment of schizophrenia in adults (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 26, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Psychiatry Patient care antipsychotic Latest News long-acting therapy paliperidone palmitate schizophrenia xeplion Source Type: news
Charity announces first programme to tackle superbugs
Antibiotic Research UK will announce at its Annual General meeting its first research programme to tackle antibiotic resistant bacteria (superbugs) (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 19, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Drug development Drug discovery Infectious Disease Patient care Research antibiotic research uk antibiotic resistance Antibiotic Resistance Breakers Latest News superbugs Source Type: news
Sobi and Biogen release interim results from the B-YOND study
Results from B-YOND study reinforce long-term clinical profile of Alprolix for the treatment of haemophilia B (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 18, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Other conferences & symposia Haematology Latest News Source Type: news
AOP Orphan announces launch of access program for EGRIFTA®
AOP Orphan announces launch of access program for the world’s first drug against lipodystrophy in HIV patients, EGRIFTA®, in Europe (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 11, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Specials and orphan drugs Patient care Research access program cardiovascular disease EGRIFTA GHRH hiv Latest News lipids lipodystrophy metabolic changes Tesamorelin Source Type: news
Opioid-induced bowel dysfunction
Due to complex symptomatology in opioid-induced bowel dysfunction, laxatives are rarely sufficient and peripheral opioid antagonists could be considered as additional treatment in these patients (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 10, 2015 Category: Drugs & Pharmacology Authors: ebercott Tags: Gastroenterology Featured Articles Source Type: news
Newcastle gets £5 million to boost drug development
Cancer Research UK’s Drug Discovery Committee* has awarded Newcastle University’s Northern Institute of Cancer Research £5M to bring more cancer drugs to clinical trials (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 10, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Drug development Oncology clinical trials CRUK drug discovery committee investment Latest News newcastle university NICR research Source Type: news
